No Data
No Data
Hyde Park Capital Advises Eleven Physician-Owned Entities in Their Strategic Partnership With Surgery Partners to Form Midwest Orthopedic and Musculoskeletal Alliance (MOMA)
Analysts Are Optimistic We'll See A Profit From Surgery Partners, Inc. (NASDAQ:SGRY)
Is Surgery Partners (NASDAQ:SGRY) A Risky Investment?
Slowing Rates Of Return At Surgery Partners (NASDAQ:SGRY) Leave Little Room For Excitement
Surgery Partners (NASDAQ:SGRY) Shareholder Returns Have Been Enviable, Earning 417% in 5 Years
Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $50
No Data
No Data